Competing/conflicts of interest: No stated conflict of interest
Letter to the Editor
Proliferative retinopathy in Duchenne muscular dystrophy and its response to bevacizumab
Version of Record online: 6 DEC 2012
© 2012 The Authors. Clinical and Experimental Ophthalmology © 2012 Royal Australian and New Zealand College of Ophthalmologists
Clinical & Experimental Ophthalmology
Volume 40, Issue 9, pages 906–907, December 2012
How to Cite
Fagan, X. J., Levy, J., Al-Qureshi, S. and Harper, C. A. (2012), Proliferative retinopathy in Duchenne muscular dystrophy and its response to bevacizumab. Clinical & Experimental Ophthalmology, 40: 906–907. doi: 10.1111/j.1442-9071.2012.02822.x
Funding sources: Dr Xavier J Fagan is currently employed as a retinal fellow at Royal Victorian Eye and Ear Hospital. The fellowship is sponsored by Novartis.
- Issue online: 6 DEC 2012
- Version of Record online: 6 DEC 2012
- Accepted manuscript online: 18 MAY 2012 04:01AM EST
- Received 17 March 2012; accepted 23 March 2012.